Abstract
Intellectual disabilities (ID) and autism spectrum disorders (ASD) have a variety of etiologies, including environmental and genetic factors. Our study reports a psychiatric clinical investigation and a molecular analysis using whole exome sequencing (WES) of two siblings with ID and ASD from a consanguineous family. Bioinformatic prediction and molecular docking analysis were also carried out. The two patients were diagnosed with profound intellectual disability, brain malformations such as cortical atrophy, acquired microcephaly, and autism level III. The neurological and neuropsychiatric examination revealed that P2 was more severely affected than P1, as he was unable to walk, presented with dysmorphic feature and exhibited self and hetero aggressive behaviors. The molecular investigations revealed a novel TRAPPC9 biallelic nonsense mutation (c.2920 C > T, p.R974X) in the two siblings. The more severely affected patient (P2) presented, along with the TRAPPC9 variant, a new missense mutation c.166 C > T (p.R56C) in the MID2 gene at hemizygous state, while his sister P1 was merely a carrier. The 3D modelling and molecular docking analysis revealed that c.166 C > T variant could affect the ability of MID2 binding to Astrin, leading to dysregulation of microtubule dynamics and causing morphological abnormalities in the brain. As our knowledge, the MID2 mutation (p.R56C) is the first one to be detected in Tunisia and causing phenotypic variability between the siblings. We extend the genetic and clinical spectrum of TRAPPC9 and MID2 mutations and highlights the possible concomitant presence of X-linked as well as autosomal recessive inheritance to causing ID, microcephaly, and autism.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
May ME, Kennedy CH. Health and problem behavior among people with intellectual disabilities. Behav Anal Pr. 2010;3:4–12.
Battle DE. Diagnostic and Statistical Manual of Mental Disorders (DSM). Codas. 2013;25:191–2.
Hodges H, Fealko C, Soares N. Autism spectrum disorder: definition, epidemiology, causes, and clinical evaluation. Transl Pediatr. 2020;9:S55–65.
Bodnar B, DeGruttola A, Zhu Y, Lin Y, Zhang Y, Mo X, et al. Emerging role of NIK/IKK2-binding protein (NIBP)/Trafficking protein particle complex 9 (TRAPPC9) in nervous system diseases. Transl Res. 2020;224:55–70.
Marangi G, Leuzzi V, Manti F, Lattante S, Orteschi D, Pecile V, et al. TRAPPC9-related autosomal recessive intellectual disability: report of a new mutation and clinical phenotype. Eur J Hum Genet. 2013;21:229–32.
Chiurazzi P, Kiani AK, Miertus J, Paolacci S, Barati S, Manara E, et al. Genetic analysis of intellectual disability and autism. Acta Biomed. 2020;91:e2020003.
Kochinke K, Zweier C, Nijhof B, Fenckova M, Cizek P, Honti F, et al. Systematic phenomics analysis deconvolutes genes mutated in intellectual disability into biologically coherent modules. Am J Hum Genet. 2016;98:149–64.
Tejada MI, Ibarluzea N. Non-syndromic X linked intellectual disability: current knowledge in light of the recent advances in molecular and functional studies. Clin Genet. 2020;97:677–87.
Ts G, Ka M, MK, GK, Rc J, Bk T. Targeted deep resequencing identifies MID2 mutation for X-linked intellectual disability with varied disease severity in a large kindred from India. Human Mutat. 2014;35. Available from: https://pubmed.ncbi.nlm.nih.gov/24115387/.
Schuler BA, Nelson ET, Koziura M, Cogan JD, Hamid R, Phillips JA. Lessons learned: next-generation sequencing applied to undiagnosed genetic diseases. J Clin Invest. 2022;132. Available from: https://www.jci.org/articles/view/154942.
Sparrow SS, Cicchetti DV. The vineland adaptive behavior scales. In: Major psychological assessment instruments, Vol 2. Needham Heights, MA, US: Allyn & Bacon; 1989. p. 199–231.
Rellini E, Tortolani D, Trillo S, Carbone S, Montecchi F. Childhood Autism Rating Scale (CARS) and Autism Behavior Checklist (ABC) correspondence and conflicts with DSM-IV criteria in diagnosis of autism. J Autism Dev Disord. 2004;34:703–8.
Chouchen J, Mahfood M, Alobathani M, Eldin Mohamed WK, Tlili A. Clinical heterogeneity of the SLC26A4 gene in UAE patients with hearing loss and bioinformatics investigation of DFNB4/Pendred syndrome missense mutations. Int J Pediatr Otorhinolaryngol. 2021;140:110467.
Schwarz JM, Cooper DN, Schuelke M, Seelow D. MutationTaster2: mutation prediction for the deep-sequencing age. Nat Methods. 2014;11:361–2.
Hu J, Ng PC. Predicting the effects of frameshifting indels. Genome Biol. 2012;13:R9.
Yan Y, Zhang D, Zhou P, Li B, Huang SY. HDOCK: a web server for protein–protein and protein–DNA/RNA docking based on a hybrid strategy. Nucleic Acids Res. 2017;45:W365–73.
Lee JH, Huang CF, Chuang YJ, Lee CY, Yu WH, Wu CC, et al. Identifying new liver X receptor alpha modulators and distinguishing between agonists and antagonists by crystal ligand pocket screening. Future Med Chem. 2020; Available from: https://www.future-science.com/doi/abs/10.4155/fmc-2020-0069.
Gholkar AA, Senese S, Lo YC, Vides E, Contreras E, Hodara E, et al. The X-linked-intellectual-disability-associated ubiquitin ligase Mid2 interacts with astrin and regulates astrin levels to promote cell division. Cell Rep. 2016;14:180–8.
Zhang Y, Bitner D, Pontes Filho AA, Li F, Liu S, Wang H, et al. Expression and function of NIK- and IKK2-binding protein (NIBP) in mouse enteric nervous system. Neurogastroenterol Motil. 2014;26:77–97.
Abbasi AA, Blaesius K, Hu H, Latif Z, Picker-Minh S, Khan MN, et al. Identification of a novel homozygous TRAPPC9 gene mutation causing non-syndromic intellectual disability, speech disorder, and secondary microcephaly. Am J Med Genet B Neuropsychiatr Genet. 2017;174:839–45.
Liang ZS, Cimino I, Yalcin B, Raghupathy N, Vancollie VE, Ibarra-Soria X, et al. Trappc9 deficiency causes parent-of-origin dependent microcephaly and obesity. PLoS Genet. 2020;16:e1008916.
Mir A, Kaufman L, Noor A, Motazacker MM, Jamil T, Azam M, et al. Identification of mutations in TRAPPC9, which encodes the NIK- and IKK-beta-binding protein, in nonsyndromic autosomal-recessive mental retardation. Am J Hum Genet. 2009;85:909–15.
Mochida GH, Mahajnah M, Hill AD, Basel-Vanagaite L, Gleason D, Hill RS, et al. A truncating mutation of TRAPPC9 is associated with autosomal-recessive intellectual disability and postnatal microcephaly. Am J Hum Genet. 2009;85:897–902.
Philippe O, Rio M, Carioux A, Plaza JM, Guigue P, Molinari F, et al. Combination of linkage mapping and microarray-expression analysis identifies NF-kappaB signaling defect as a cause of autosomal-recessive mental retardation. Am J Hum Genet. 2009;85:903–8.
Koifman A, Feigenbaum A, Bi W, Shaffer LG, Rosenfeld J, Blaser S, et al. A homozygous deletion of 8q24.3 including the NIBP gene associated with severe developmental delay, dysgenesis of the corpus callosum, and dysmorphic facial features. Am J Med Genet A. 2010;152A:1268–72.
Abou Jamra R, Wohlfart S, Zweier M, Uebe S, Priebe L, Ekici A, et al. Homozygosity mapping in 64 Syrian consanguineous families with non-specific intellectual disability reveals 11 novel loci and high heterogeneity. Eur J Hum Genet. 2011;19:1161–6.
Kakar N, Goebel I, Daud S, Nürnberg G, Agha N, Ahmad A, et al. A homozygous splice site mutation in TRAPPC9 causes intellectual disability and microcephaly. Eur J Med Genet. 2012;55:727–31.
Giorgio E, Ciolfi A, Biamino E, Caputo V, Di Gregorio E, Belligni EF, et al. Whole exome sequencing is necessary to clarify ID/DD cases with de novo copy number variants of uncertain significance: two proof-of-concept examples. Am J Med Genet A. 2016;170:1772–9.
Mortreux J, Busa T, Germain DP, Nadeau G, Puechberty J, Coubes C, et al. The role of CNVs in the etiology of rare autosomal recessive disorders: the example of TRAPPC9-associated intellectual disability. Eur J Hum Genet. 2018;26:143–8.
Duerinckx S, Meuwissen M, Perazzolo C, Desmyter L, Pirson I, Abramowicz M. Phenotypes in siblings with homozygous mutations of TRAPPC9 and/or MCPH1 support a bifunctional model of MCPH1. Mol Genet Genom Med. 2018;6:660–5.
Hnoonual A, Graidist P, Kritsaneepaiboon S, Limprasert P. Novel compound heterozygous mutations in the TRAPPC9 gene in two siblings with autism and intellectual disability. Front Genet. 2019;10:61.
Bai Z, Kong X. [Diagnosis of a case with mental retardation due to novel compound heterozygous variants of TRAPPC9 gene]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2019;36:1115–9.
Krämer J, Beer M, Bode H, Winter B. Two novel compound heterozygous mutations in the TRAPPC9 gene reveal a connection of non-syndromic intellectual disability and autism spectrum disorder. Front Genet. 2020;11:972.
Wilton KM, Gunderson LB, Hasadsri L, Wood CP, Schimmenti LA. Profound intellectual disability caused by homozygous TRAPPC9 pathogenic variant in a man from Malta. Mol Genet Genom Med. 2020;8:e1211.
Alvarez-Mora MI, Corominas J, Gilissen C, Sanchez A, Madrigal I, Rodriguez-Revenga L. Novel compound heterozygous mutation in TRAPPC9 gene: the relevance of whole genome sequencing. Genes. 2021;12:557.
Ben Ayed I, Bouchaala W, Bouzid A, Feki W, Souissi A, Ben Nsir S, et al. Further insights into the spectrum phenotype of TRAPPC9 and CDK5RAP2 genes, segregating independently in a large Tunisian family with intellectual disability and microcephaly. Eur J Med Genet. 2021;64:104373.
Yousefipour F, Mozhdehipanah H, Mahjoubi F. Identification of two novel homozygous nonsense mutations in TRAPPC9 in two unrelated consanguineous families with intellectual Disability from Iran. Mol Genet Genom Med. 2021;9:e1610.
Radenkovic S, Martinelli D, Zhang Y, Preston GJ, Maiorana A, Terracciano A, et al. TRAPPC9-CDG: a novel congenital disorder of glycosylation with dysmorphic features and intellectual disability. Genet Med. 2022;24:894–904.
Uctepe E, Yesilyurt A, Esen FN, Tümer S, Mancılar H, Sonmez FM. TRAPPC9-related intellectual disability: report of two new cases and review of the literature. Mol Syndromol. 2023;14:485–92.
Amin M, Vignal C, Eltaraifee E, Mohammed IN, Hamed AAA, Elseed MA, et al. A novel homozygous mutation in TRAPPC9 gene causing autosomal recessive non-syndromic intellectual disability. BMC Med Genomics. 2022;15:236.
Bolat H, Ünsel-Bolat G, Derin H, Şen A, Ceylaner S. Distinct autism spectrum disorder phenotype and hand-flapping stereotypes: two siblings with novel homozygous mutation in TRAPPC9 gene and literature review. Mol Syndromol. 2022;13:263–9.
Ke Y, Weng M, Chhetri G, Usman M, Li Y, Yu Q, et al. Trappc9 deficiency in mice impairs learning and memory by causing imbalance of dopamine D1 and D2 neurons. Sci Adv. 2020;6:eabb7781.
Suzuki M, Hara Y, Takagi C, Yamamoto TS, Ueno N. MID1 and MID2 are required for Xenopus neural tube closure through the regulation of microtubule organization. Development. 2010;137:2329–39.
Chakkalakal SA, Heilig J, Baumann U, Paulsson M, Zaucke F. Impact of arginine to cysteine mutations in collagen II on protein secretion and cell survival. Int J Mol Sci. 2018 ;19:541.
Kabra A, Rumpa E, Li Y. Observation of arginine side-chain motions coupled to the global conformational exchange process in deubiquitinase A. ACS Omega. 2022;7:9936–43.
Baynes BM, Wang DIC, Trout BL. Role of arginine in the stabilization of proteins against aggregation. Biochemistry. 2005;44:4919–25.
Meng F, Yao D, Shi Y, Kabakoff J, Wu W, Reicher J, et al. Oxidation of the cysteine-rich regions of parkin perturbs its E3 ligase activity and contributes to protein aggregation. Mol Neurodegener. 2011;6:34.
Acknowledgements
The authors thank the patients and their families for their cooperation in the present study. They also thank the doctors of the CHU Hedi Chaker of Sfax’s Child Neurology department for their assistance.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Kharrat, M., Triki, C., ben isaa, A. et al. Expanding the genetic and phenotypic spectrum of TRAPPC9 and MID2-related neurodevelopmental disabilities: report of two novel mutations, 3D-modelling, and molecular docking studies. J Hum Genet (2024). https://doi.org/10.1038/s10038-024-01242-9
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1038/s10038-024-01242-9